Autoantibodies: Diagnostic fingerprints and etiologic perplexities

Clinical and Investigative Medicine

Volumn 20, Issue 1, 1997, Pages 50-66

  Fritzler, Marvin J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA TOPOISOMERASE; ENZYME ANTIBODY; HISTONE; HISTONE ANTIBODY; HYDRALAZINE; MERCURY; PROCAINAMIDE;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CENTROMERE; CHROMATIN; DIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RHEUMATIC DISEASE; SCLERODERMA; SIDE EFFECT;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS;

EID: 0031050603     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (174)

1. Martin L, Fritzler MJ. Autoantibodies. In: Stein JH, editor. Autoantibodies. St. Louis (MO): Mosby, 1994:2349-56.
2. Von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic disease. Semin Arthritis Rheum 1995;24:323-58.
3. Song Y, Maclaren NK. The nature of autoantigens targeted in autoimmune endocrine diseases. Immunol Today 1996;17:232-8.
4. Volpé R. Autoimmune endocrinopathies: aspects of pathogenesis and the role of immune assays in investigation and management. Clin Chem 1994;40:2132-45.
5. Tan EM. Autoantibodies in pathology and cell biology. Cell 1991;67:841-2.
6. Chan EKL, Andrade LEC. Antinuclear antibodies in Sjögren's syndrome. Rheum Dis Clin North Am 1992;18:551-70.
7. Fritzler MJ. Autoantibodies in scleroderma. J Dermatol 1993;20:257-68.
8. Fritzler MJ, Salazar M. The diversity and origin of rheumatologic autoantibodies. Clin Microbiol Rev 1991;4:256-69.
9. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271.
11. Kasukawa R. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Preliminary diagnostic criteria for classification of mixed connective tissue disease. Amsterdam: Excerpta Medica, 1987:41-7.
12. Habets WJ, De Rooij DJ, Salden MH, et al. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 1983;54:265-76.
13. Kotajima L, Aotsuka S, Sumiya M, et al. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nation-wide collaborative study in Japan. J Rheumatol 1996;23:1088-94.
14. Fox RI, Robinson CA, Curd JG, et al. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
15. Kunkel SL, Strieter RM, Lindley IJD, et al. Diagnostic criteria and immunopathogenesis of Sjögren's syndrome: implications for therapy. Immunol Today 1995;16:557-9.
16. Decker JL, Esdaile JM, Fritzler MJ, et al. Humoral immune phenomena. In: Dictionary of the rheumatic diseases, vol 2: diagnostic testing. New York: Contact Associates International, 1987:15-24.
17. Tan EM, Fritzler MJ, McDougal JS, et al. Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum 1982;25:1003-5.
18. Fritzler MJ, Pauls JD, Kinsella TD, et al. Antinuclear, anticytoplasmic and anti-Sjögren's syndrome antigen-A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985;36:120-8.
19. Aho K, Koskela P, Makitalo R. Antinuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol 1992;19:1377-9.
20. Tan EM. Autoantibodies to nuclear antigens. Adv Immunol 1982;33:167-240.
21. Winfield JB, Faiferman I, Koffler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus (association of high avidity antinative DNA antibody with glomerulonephritis). J Clin Invest 1977;59:90-6.
22. Tron F, Bach JF. Relationships between antibodies to native DNA and glomerulonephritis in SLE. Clin Exp Immunol 1977;28:426-32.
23. Weiner ES, Hildebrandt S, Senecal JL, et al. Prognostic significance of anticentromere antibodies and antitopoisomerase I antibodies in Raynaud's disease. Arthritis Rheum 1991;34:68-77.
24. Kallenberg CGM. Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex. Clin Rev Allergy 1994;12:221-35.
25. Esdaile JM, Abrahamowicz M, Joseph L, et al. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus -why some tests fail. Arthritis Rheum 1996;39:370-8.
26. Vallee BL, Coleman JE, Auld DS. Zinc fingers, zinc clusters, and zinc twists in DNA-binding protein domains. Proc Natl Acad Sci U S A 1991;88:999-1003.
27. Weinstein A, Bordwell B, Stone B, et al. Antibodies to native DNA and serum complement (C3) levels: application to diagnosis and classification of systemic lupus erythematosus. Am J Med 1983;74:206-16.
28. Swaak AJG, Groenwold J, Aarden LA, et al. Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 1982;41:388-95.
29. Petri M, Genovese M, Engle E, et al. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. Arthritis Rheum 1991;34:937-44.
30. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991;70:360-74.
31. Targoff IN. Immunologic aspects of polymyositis. Curr Opin Rheumatol 1989;1:432-42.
32. Miller FW. Myositis-specific autoantibodies. Touch-stones for understanding the inflammatory myopathies. JAMA 1993;270:1846-9.
33. Plotz PH, Rider LG, Targoff IN, et al. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995; 122:715-24.
34. Tan EM, Chan EKL. Molecular biology of autoantigens and new insights into autoimmunity. Clin Invest 1993;71:327-30.
35. Tan EM, Chan EKL, Sullivan KF, et al. Antinuclear antibodies (ANAs): diagnositically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 1988;47:121-41.
36. Shlomchik M, Mascelli M, Shan H, et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990; 171:265-92.
37. Shan H, Shlomchik MJ, Marshak-Rothstein A, et al. The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J Immunol 1994;153:5104-20.
38. Theofilopoulos AN. Genetics of systemic autoimmunity. J Autoimmun 1996;9:207-10.
39. Demaine AG. The molecular biology of autoimmune disease. Immunol Today 1989;10:357.
40. Nossal GJV. Negative selection of lymphocytes. Cell 1994;76:219-39.
41. Tan EM. Autoimmunity and apoptosis. J Exp Med 1994;179:1083-6.
42. Fritzler MJ. Histone antibodies. In: Dubois EL, Hahn B, Wallace DJ, editors. Dubois' lupus erythematosus. 4th ed. Philadelphia: Lea & Febiger, 1993:202-15.
43. Fritzler MJ, Rubin RL. Drug-induced lupus. In: Dubois EL, Hahn B, Wallace DJ, editors. Dubois' lupus erythematosus. 4th ed. Philadelphia: Lea & Febiger, 1993:442-53.
44. Rubin RL, Burlingame RW. Biochemical mechanisms in autoimmunity. Biochem Soc Trans 1991;19:153-9.
45. Miller BJ, Pauls JD, Fritzler MJ. Human monoclonal antibodies demonstrate polyspecificity for histones and the cytoskeleton. J Autoimmun 1991;4:665-79.
46. Nassberger L, Johansson AC, Bjorck S, et al. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment. J Intern Med 1991;229:261-5.
47. Jacob L, Viard J, Allenet B, et al. A monoclonal antidouble-stranded DNA autoantibody binds to a 94-kDa cell surface protein on various cell types via nucleosomes or a DNA-histone complex. Proc Natl Acad Sci U S A 1989;86:4669-73.
48. Rekvig OP. Intrinsic cell membrane antigens recognized by antichromatin autoantibodies. Scand J Immunol 1989;29:7-13.
49. Bennett RM, Davis J, Campbell S, et al. Lactoferrin binds to cell membrane DNA (association of surface DNA with an enriched population of B cells and monocytes). J Clin Invest 1983;71:611-8.
50. Bennett RM, Davis J, Merritt M. Anti-DNA antibodies react with DNA expressed on the surface of monocytes and the cell surface. J Rheumatol 1986;13:679-85.
51. Rekvig OP, Muller S, Briand JP, et al. Human antinuclear autoantibodies crossreacting with the plasma membrane and the N-terminal region of histone H2B. Immunol Invest 1987;16:535-47.
52. VenKatraman JT, Gohill J, Fritzler MJ, et al. A histone 1-like antigen is a component of the nuclear envelope. Biochem Biophys Res Commun 1988;156:675-80.
53. Viard J-P, Chabre H, Bach J-F. Autoantibodies to nucleosomes in HIV-I-infected patients. J Acquir Immune Defic Syndr 1994;7:1286-7.
54. Muller S, Barakat S, Watts R, et al. Longitudinal analysis of antibodies to histones, Sm-D peptides and ubiquitin in the serum of patients with systemic lupus erythematosus, rheumatoid arthritis and tuberculosis. Clin Exp Rheumatol 1990;8:445-53.
55. Fredriksen K, Traavik T, Flaegstad T, et al. BK virus terminates tolerance to dsDNA and histone antigens in vivo. Immunol Invest 1990;19:133-51.
56. Imaoka K, Kanai Y, Yoshikawa Y, et al. Temporary breakdown of immunological tolerance to dsDNA and nucleohistone antigens in rabbits infected with rinderpest virus. Clin Exp Immunol 1990;82:522-6.
57. Monestier M, Kotzin BL. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. Rheum Dis Clin North Am 1992;18:415-36,
58. Williams DG. Recominant autoantigens. Ann Rheum Dis 1990;49:445-51.
59. Hardin JA. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1986;29:457-60.
60. Burlingame RW, Rubin RL, Balderas RS, et al. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 1993;91:1687-96.
61. Mohan C, Adams S, Stanik V, et al. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993;177:1367-81.
62. Amoura Z, Chabre H, Koutouzov S, et al. Nucleosome-restricted antibodies are detected before anti-ds-DNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994;37:1684-8.
63. Fournié GJ. Circulating DNA and lupus nephritis. Kidney Int 1988;33:487.
64. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurence as multimeric complexes bound to histone. J Clin Invest 1990;86:69-74.
65. Losman JA, Fasy TM, Novick KE, et al. Nucleosome-specific antibody from an autoimmune MRL/Mp-lpr/lpr mouse. Arthritis Rheum 1993;36:552-60.
66. Tax WJM, Kramers C, van Bruggen MCJ, et al. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int 1995;48:666-73.
67. Burlingame RW, Boey ML, Starkebaum G, et al. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994;94:184-92.
68. Burlingame RW, Love WE, Wang BC, et al. Crystallo-graphic structure of the octameric histone core of the nucleosome at a resolution of 3.3 A. Science 1985;228: 546-53.
69. Arents G, Burlingame RW, Wang BC, et al. The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix. Proc Natl Acad Sci U S A 1991;88:10148-52.
70. Burlingame RW, Rubin RL. Histones. In: van Venrooij WJ, Maini RN, editors. Histones. Boston: Kluwer Academic Publishers, 1993:1-28.
71. Mendelson E, Bustin M. Monoclonal antibodies against distinct determinants of histone H5 bind to chromatin. Biochemistry 1984;23:3459-66.
72. Hengartner C, Lagueux J, Poirier GG. Analysis of the activation of poly (ADP-ribose) polymerase by various types of DNA. Biochem Cell Biol 1991;69:577-80.
73. Einck L, Dibble R, Frado LLY, et al. Nucleosomes as antigens: characterization of determinants and cross-reactivity. Exp Cell Res 1982;54:320-32.
74. Gohill J, Cary PD, Couppez M, et al. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J Immunol 1985; 135:3116-21.
75. Pauls JD, Silverman E, Laxer RM, et al. Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1989;32:877-83.
76. Craft JE, Radding JA, Harding MW, et al. Autoantigenic histone epitopes: a comparison between procainamide- and hydralazine-induced lupus. Arthritis Rheum 1987;30:689-94.
77. Bell DA, Morrison B, VandenBygaart P. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse and human B lymphocytes. J Clin Invest 1990;85:1487-96.
78. Bigazzi PE. Lessons from animal models: the scope of mercury-induced autoimmunity. Clin Immunol Immunopathol 1992;65:81-4.
79. Pelletier L, Pasquier R, Rossert J, et al. Autoreactive T cells in mercury-induced autoimmunity. J Immunol 1988;140:750-4.
80. Hultman P, Enestrom S. Mercury induced B-cell activation and antinuclear antibodies in mice. J Clin Lab Immunol 1989;28:143-50.
81. Hua J, Pelletier L, Berlin M, et al. Autoimmune glomerulonephritis induced by mercury vapour exposure in the brown Norway rat. Toxicology 1993;79:119-29.
82. Kosuda LL, Greiner DL, Bigazzi PE. Mercury-induced renal autoimmunity in BN LEW. IN chimeric rats. Cell Immunol 1994;155:77-94.
83. Druet E, Guery J-C, Ayed K, et al. Characteristics of polyreactive and monospecific IgG anti-laminin autoantibodies in the rat mercury model. Immunology 1994;83:489-94.
84. Hultman P, Enestrom S. Dose-response studies in murine mercury-induced autoimmunity and immunecomplex disease. Toxicol Appl Pharmacol 1992;113: 199-208.
85. 2-induced autoimmunity. Clin Exp Immunol 1991;86:118-23.
86. Aten J, Veninga A, Bruijn JA, et al. Antigenic specificities of glomerular-bound autoantibodies in membranous glomerulopathy induced by mercuric chloride. Clin Immunol Immunopathol 1992;63:89-102.
87. Van der Meide PH, de Labi MCDC, Botman CAD, et al. Mercuric chloride down-regulates T cell interferon-γ production in brown Norway but not in Lewis rats; role of glutathione. Eur J Immunol 1993;23:675-81.
88. Kosuda LL, Greiner DL, Bigazzi PE. Mercury-induced renal autoimmunity: changes in RT6+ T-lymphocytes of susceptible and resistant rats. Environ Health Perspect 1993;101:178-85.
89. 2-induced membranous glomerulopathy. Am J Pathol 1995;146:1467-80.
90. Hultman P, Enestrom S, Pollard KM, et al. Anti-fibrillarin antibodies in mercury-treated mice. Clin Exp Immunol 1989;78:470-2.
91. Takeuchi K, Turley SJ, Tan EM, et al. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. J Immunol 1995;154:961-71.
92. Hultman P, Bell LJ, Enestrom S, et al. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol 1992;65:98-109.
93. Hultman P, Bell LJ, Enestrom S, et al. Murine susceptibility to mercury. II. Autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenie mice. Clin Immunol Immunopathol 1993;68:9-20.
94. Hultman P, Ganowiak K, Turley SJ, et al. Genetic susceptibility to silver-induced anti-fibrillarin autoantibodies in mice. Clin Immunol Immunopathol 1995;77: 291-7.
95. Hultman P, Turley SJ, Enestrom S, et al. Murine geno-type influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J Autoimmun 1996;9:139-49.
96. Lernmark A, Barmeier H, Dube S, et al. Autoimmunity of diabetes. Endocrinology 1991;20:589.
97. Faustman D. Mechanisms of autoimmunity in Type 1 diabetes. J Clin Invest 1993;13:1-7.
98. Drachman DB, Adams RN, Josifek LF, et al. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982;307:769-75.
99. Sterz RKM, Biro G, Rajki K, et al. Experimental autoimmune myasthenia gravis: can pretreatment with i-labeled receptor prevent functional damage at the neuromuscular junction? J Immunol 1985;134:841-7.
100. Gomez CM, Richman DP. Anti-acetylcholine receptor antibodies directed against the a-bungarotoxin binding site induce a unique form of experimental myasthenia. Proc Natl Acad Sci U S A 1983;80:4089-93.
101. Eckhardt SJ. Paraneoplastic syndromes. Cancer Surv 1994;21:197-210.
102. Posner JB. Paraneoplastic cerebellar degeneration. Can J Neurol Sci 1993;20:S117-S122.
103. Dalmau J, Posner JB. Neurological paraneoplastic syndromes. Springer Semin Immunopathol 1996;85-95.
104. Pelucchi A, Ciceri E, Clementi F, et al. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer. Am Rev Respir Dis 1993;147:1229-32.
105. Dropcho EJ, Stanton C, Oh SJ. Neuronal antinuclear antibodies in a patient with Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Neurology 1989;39:249-51.
106. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-74.
107. David C, Solimena M, De Camilli P. Autoimmunity in stiff-man syndrome with breast cancer is targeted to the C-terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161. FEBS Lett 1994;351:73-9.
108. Folli F, Solimena M, Cofiell R, et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med 1993;328:546-51.
109. Grimaldi LME, Martino G, Braghi S, et al. Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol 1993;34:57-64.
110. Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy. Medicine 1992;71:59-72.
111. Posner JB. Anti-Hu autoantibody associated sensory neuropathy/encephalomyelitis: a model of paraneoplastic syndrome. Perspect Biol Med 1995;38:167-81.
112. Szabo A, Dalmau J, Manley G, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to elav and sex-lethal. Cell 1991;67:325-33.
113. Vega F, Graus F, Chen QM, et al. Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation. Neurology 1994;44:2145-7.
114. Dalmau J, Graus F, Cheung N-KV, et al. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 1995;75:99-109.
115. Sekido Y, Bader SA, Carbone DP, et al. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines. Cancer Res 1994;54:4988-92.
116. Budde-Steffen C, Anderson N, Rosenblum MK, et al. An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 1988;23:528-31.
117. Luque FA, Furneaux HM, Ferziger R, et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991;29:241-51.
118. Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1996;19:1-47.
119. Hersh B, Dalmau J, Dangond F, et al. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology 1994;44:1754-5.
120. Fathallah-Shaykn H, Wolf S, Wong E, et al. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A 1991;88:3451-4.
121. Dropcho EJ, Chen Y, Posner JB, et al. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A 1987;84:4552-6.
122. Joly P, Thomine E, Gilbert D, et al. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol 1994;103:65-72.
123. Kanitakis J, Wang YZ, Roche P, et al. Immunohistopathological study of autoimmune pemphigus. Lack of strictly specific histological and indirect immunoflurescence criteria for paraneoplastic pemphigus. Dermatology 1994;188:282-5.
124. Hashimoto T, Amagai M, Watanabe K, et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995;104: 829-34.
125. Polans AS, Wotowska D, Haley TL, et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U S A 1995;92:9176-80.
126. Sakai K, Ogasawara T, Hirose G, et al. Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins. Ann Neurol 1993;33:373-80.
127. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 1988;24:559-67.
128. Dalmau JO, Posner JB. Purkinje cell antibodies. Type I (Yo). In: Peter JB, Shoenfeld Y, editors. Autoantibodies. The Netherlands: Elsevier Science, 1996:655-9.
129. Lennon VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 1994;44:2236-40.
130. Dalmau J, Posner JB. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology 1994;44:2241-6.
131. Tanaka K, Tanaka M, Onodera O, et al. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J Neurol Sci 1994;127:153-8.
132. Horwich MS, Cho L, Porro RS, et al. Subacute sensory neuropathy: a remote effect of cancer. Ann Neurol 1977;2:7-19.
133. Dalmau J, Furneaux HM, Gralla RJ, et al. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - a quantitative western blot analysis. Ann Neurol 1990;27:544-52.
134. Graus F, Elkon KB, Lloberes P, et al. Neuronal antinuclear antibody (anti-Hu) in paraneoplastic encephalomyelitis simulating acute polyneuritis. Acta Neurol Scand 1987;75:249-52.
135. Anderson NE, Rosenblum MK, Graus F, et al. Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurology 1988;38:1391-8.
136. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 1986;80(1):45-52.
137. Tan EM. Do autoantibodies inhibit function of their cognate antigens in vivo? Arthritis Rheum 1989; 32:924.
138. Alarcon-Segovia D, Llorente L. Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T gamma cells. Clin Exp Immunol 1983;52:365-71.
139. Llerena JM, Ruiz-Arguelles A, Alarcon-Segovia D, et al. Antibody penetration into living cells. V. Interference between two Fc gamma receptor-mediated functions: antibody penetration and antibody-dependent cellular cytotoxicity. Immunology 1981;43:249-54.
140. Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol Today 1996;163-4.
141. Golan TD, Gharavi AE, Elkon KB. Penetration of autoantibodies into living epithelial cells. J Invest Dermatol 1993;100:316-22.
142. Reimer G, Raska I, Tan EM, et al. Human autoantibodies: probes for nucleolus structure and function. Virchows Arch B 1987;54:131-43.
143. Meziere C, Stockl F, Batsford S, et al. Antibodies to DNA, chromatin core particles and histones in mice with graft-versus-host disease and their involvement in glomerular injury. Clin Exp Immunol 1994;98:287-94.
144. Buyon JP, Winchester RJ, Slade SG, et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Arthritis Rheum 1993;36:1263-73.
145. Julkunen H, Kurki P, Kaaja R, et al. Isolated congenital heart block. Long-term outcome of mothers and characteristics of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993;36:1588-98.
146. Lee LA, Frank MB, McCubbin VR, et al. Autoantibodies of neonatal lupus erythematos us. J Invest Dermatol 1994;102:963-6.
147. Frank MB, Itoh K, Fujisaku A, et al. The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. Am J Hum Genet 1993;52:183-91.
148. Chan EKL, Hamel JC, Buyon JP, et al. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 1991;87: 68-76.
149. Itoh K, Itoh Y, Frank MB. Protein heterogeneity in the human Ro/SS-A ribonucleoproteins: the 52- and 60-kDA Ro/SS-A autoantigens are encoded on separate genes. J Clin Invest 1991;87:177-86.
150. Takahashi M, Inaguma Y, Hai H, et al. Developmentally regulated expression of a human "finger"-containing gene encoded by 5′ half of the ret transformation gene. Mol Cell Biol 1988;8:1853-6.
151. Patarca R, Freeman GJ, Schwartz J, et al. rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type I. Proc Natl Acad Sci U S A 1988;85:2733-7.
152. Vogelstein B, Kinzler KW. Has the breast cancer gene been found? Cell 1994;79:1-3.
153. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science 1994;266:66-71.
154. Fritzler MJ, Lung C, Hamel JC, et al. Molecular characterization of golgin-245: a novel Golgi complex protein containing a granin signature. J Biol Chem 1995; 270:31262-8.
155. Yang CH, Lambie EJ, Snyder M. NuMA: an unusually long coiled-coil related protein in the mammalian nucleus. J Cell Biol 1992;116:1303-17.
156. Yaneva M, Wen J, Ayala A, et al. cDNA-derived amino acid sequence of the 86-kDa subunit of the Ku antigen. J Biol Chem 1989;264:13407-11.
157. Chou C-H, Reeves WH. Recognition of multiple epitopes in the coiled-coil domain of lamin B by human autoantibodies. Mol Immunol 1992;29:1055-64.
158. Pollard KM, Chan EKL, Grant BJ, et al. In vitro post-translational modification of lamin B cloned from a human T-cell line. Mol Cell Biol 1990;10:2164-75.
159. Cunningham MW, Antone SM, Gulizia JM, et al. α-Helical coiled-coil molecules: a role in autoimmunity against the heart. Clin Immunol Immunopathol 1993;68:118-23.
160. McCormack JM, Crossley CA, Ayoub EM, et al. Post-streptococcal anti-myosin antibody idiotype associated with systemic lupus erythematosus and Sjögren's syndrome. J Infect Dis 1993;168:915-21.
161. Liao H, Winkfein RJ, Mack G, et al. CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J Cell Biol 1995;130:507-18.
162. Sakai K, Mitchell DJ, Tsukamoto T, et al. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol 1990;28:692-8.
163. Chan EKL, Di Donato F, Hamel JC, et al. 52-kD SS-A/Ro: genomic structure and identification of alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart. J Exp Med 1995;182:983-92.
164. Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978;121:2228-34.
165. Fritzler MJ, McCarty GA, Ryan JP, et al. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen (PCNA). Arthritis Rheum 1983;26:140-5.
166. Takasaki Y, Deng J-S, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 1981;154:1899-909.
167. Morris GF, Mathews MB. Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 1989;264:13856-64.
168. Tan CK, Castillo C, So AG, et al. An auxiliary protein for DNA polymerase delta from fetal calf thymus. J Biol Chem 1986;261:12310-6.
169. Shivji MKK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992;69:367-74.
170. Zeng XR, Jiang Y, Zhang SJ, et al. DNA polymerase delta is involved in the cellular response to UV damage in human cells. J Biol Chem 1994;269:13748-51.
171. Bravo R, Frank R, Blundell PA, et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987;326:515.
172. Krishna TSR, Kong X-P, Gary S, et al. Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell 1994;79:1233-43.
173. Brand SR, Bernstein RM, Mathews MB. Trimeric structure of human proliferating cell nuclear antigen: implications for enzymatic function and autoantibody recognition. J Immunol 1994;153:3070-8.
174. Tan C-K, Sullivan K, Li X, et al. Autoantibody to the proliferating cell nuclear antigen neutralizes the activity of the auxilary protein for DNA polymerase delta. Nucleic Acids Res 1987;15:9299-308.